disease remains poor. We demonstrate here that arginase 2 (ARG2) drives neuroblastoma
cell proliferation via regulation of arginine metabolism. Targeting arginine metabolism, either
by blocking cationic amino acid transporter 1 (CAT-1)–dependent arginine uptake in vitro or
therapeutic depletion of arginine by pegylated recombinant arginase BCT-100, significantly
delayed tumor development and prolonged murine survival. Tumor cells polarized infiltrating …